Post Type Archives: News

Inizio today announced the official launch of its fully integrated, end-to-end Hub Services, a cornerstone of its market-leading Patient Solutions offering. Delivered by Inizio Engage, the Inizio business unit specializing in patient engagement and support, this next-generation solution addresses the growing complexity of patient access, reimbursement, and adherence, while enabling clients to partner with a more agile, strategic, and […]

Merck, known as MSD outside of the United States and Canada, and Google Cloud announced an AI-focused partnership on April 22, 2026. The investment, valued at up to $1 billion, will see Merck integrate various Google Cloud technologies across various areas of their business operations. According to a company press release, Google Cloud’s AI technology […]

Eli Lilly & Company and Kelonia Therapeutics, a clinical-stage biotechnology company developing methods for in vivo gene delivery, announced a definitive acquisition agreement on April 20th, 2026. Eli Lilly will pay up to $7 billion, including an upfront payment of $3.25 billion, to acquire Kelonia Therapeutics. Kelonia’s assets include lead program KLN-1010, an investigational gene […]

Merck, known as MSD outside of the United States and Canada, announced FDA approval of Idyvynso for the treatment of adults with HIV-1 on April 21st, 2026. Consisting of a single tablet comprising 100 mg doravirine and 0.25 mg islatravir, the treatment is indicated as a replacement for antiretroviral regimens in those who are virologically […]

Alcami Corporation, a leading U.S.-based contract development and manufacturing organization (CDMO), today announced it has entered into a definitive agreement to acquire Tjoapack, a leading global contract packaging organization with facilities in the United States and The Netherlands. Tjoapack has been a trusted supplier of contract primary and secondary packaging solutions for more than 35 […]

Indena is proud to announce its participation in CPHI Japan 2026, taking place from April 21-23 at the Tokyo Big Sight Exhibition Center. As a beacon of research and development for over a century and a leading cGMP Contract Development and Manufacturing Organization (CDMO) for over 35 years, Indena will showcase its advanced capabilities and […]

Informa Markets will once again bring together the pharmaceutical industry at CPHI Americas 2026 (June 2-4), uniting senior leaders from across the pharmaceutical supply chain for a revamped conference focused event on contract manufacturing, regulatory change, artificial intelligence, and innovation in biologics and advanced therapies. Part of the global CPHI portfolio, the annual event serves […]

Informa Markets will once again bring together the pharmaceutical industry at CPHI Americas 2026 (June 2-4), uniting senior leaders from across the pharmaceutical supply chain for a revamped conference focused event on contract manufacturing, regulatory change, artificial intelligence, and innovation in biologics and advanced therapies. Part of the global CPHI portfolio, the annual event serves […]

Indena is proud to announce its participation in the Health Food Expo, Ingredients and Contract Manufacture 2026 in Tokyo. Leveraging the proven success and strong local presence of its Japanese branch, Indena’s participation in this event underscores its sustained and profound commitment to the thriving Japanese nutraceutical market. At this year’s expo, Indena will put […]

Ofichem has brought its brands – Ofichem BV, Ofipharma, Ofimedicine, Labatorium Ofichem, Ofichem Uppsala, and Avivia – together as one family-owned CDMO and pharmaceutical supplier, marking a strategic step in its evolution. From April 1, all business units will operate under the Ofichem trading name. The move brings together Ofichem’s capabilities across drug substance, drug […]